Human liver patient-derived HUB Organoids as a promising tool to study drug-induced liver injury and drug metabolism for improved preclinical toxicology assessment

download poster

White paper

Download to learn how to derisk and accelerate your oncology drug development program
> Download now

On demand presentation

Watch to discover how to downscale patient-derived organoid screening
> Watch now

Blog

Read our experts’ opinion on how to use organoids in drug screening
> Read more